Xi‐Ping Huang

Active 1992–2025

Also published as
Xi-Ping Huang
104
Papers
25,272
Citations
72
h-index
101
i10-index

Citations

Citations per year for Xi‐Ping Huang1967: 1 citations1982: 1 citations1985: 1 citations1987: 7 citations1992: 1 citations1993: 2 citations1994: 26 citations1995: 14 citations1996: 9 citations1997: 14 citations1998: 23 citations1999: 11 citations2000: 13 citations2001: 14 citations2002: 12 citations2003: 12 citations2004: 7 citations2005: 10 citations2006: 7 citations2007: 5 citations2008: 9 citations2009: 9 citations2010: 22 citations2011: 55 citations2012: 122 citations2013: 221 citations2014: 261 citations2015: 274 citations2016: 288 citations2017: 365 citations2018: 362 citations2019: 897 citations2020: 1,570 citations2021: 1,728 citations2022: 1,202 citations2023: 920 citations2024: 1,245 citations2025: 653 citations2026: 34 citations1968–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986: no citations, so this year is not shown1988–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,874 citing papers, 28.7% of this breakdownChina: 1,607 citing papers, 11.9% of this breakdownUnited Kingdom: 854 citing papers, 6.3% of this breakdownGermany: 688 citing papers, 5.1% of this breakdownCanada: 548 citing papers, 4.1% of this breakdownFrance: 464 citing papers, 3.4% of this breakdownItaly: 462 citing papers, 3.4% of this breakdownIndia: 423 citing papers, 3.1% of this breakdownJapan: 367 citing papers, 2.7% of this breakdownSpain: 299 citing papers, 2.2% of this breakdownAustralia: 295 citing papers, 2.2% of this breakdownSwitzerland: 277 citing papers, 2.1% of this breakdown
0%28.7%Other 24.8%

Fields

  • Biochemistry, Genetics and Molecular Biology33.3%
  • Medicine31.1%
  • Neuroscience13.6%
  • Computer Science10%
  • Immunology and Microbiology3.3%
  • Psychology2.2%
  • Other6.5%

Topics

  • Receptor Mechanisms and Signaling6.6%
  • Computational Drug Discovery Methods5.6%
  • SARS-CoV-2 and COVID-19 Research4.9%
  • Neuropeptides and Animal Physiology3.6%
  • COVID-19 Clinical Research Studies3.1%
  • Neuroscience and Neuropharmacology Research3%
  • Other73.2%

Coauthors

All papers

Open in search
  1. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bjoern Meyer, Ferdinand Roesch, Thomas Vallet, Alice Mac Kain, Lisa Miorin, Elena Moreno, Zun Zar Chi Naing, Yuan Zhou, Shiming Peng, Ying Shi, Ziyang Zhang, Wenqi Shen, Ilsa T. Kirby, James E. Melnyk, John S. Chorba, Kevin Lou, Shizhong Dai, Inigo Barrio‐Hernandez, Danish Memon, Claudia Hernández-Armenta, Jiankun Lyu, Christopher J.P. Mathy, Tina Perica, Kala Bharath Pilla, Sai J. Ganesan, Daniel J. Saltzberg, Ramachandran Rakesh, Liu Xi, Sara B. Rosenthal, Lorenzo Calviello, Srivats Venkataramanan, José Liboy-Lugo, Yizhu Lin, Xi‐Ping Huang, Yongfeng Liu, Stephanie A. Wankowicz, Markus‐Frederik Bohn, Maliheh Safari, Fatima S. Ugur, Cassandra Koh, Nastaran Sadat Savar, Quang Tran, Djoshkun Shengjuler, Sabrina Johanna Fletcher, Michael C. O’Neal, Yiming Cai, Jason C. Chang, David Broadhurst, Saker Klippsten, Phillip P. Sharp, Nicole A. Wenzell, Duygu Kuzuoğlu‐Öztürk, Hao‐Yuan Wang, Raphael Trenker, Janet M. Young, Devin A. Cavero, Joseph Hiatt, Theodore L. Roth, Ujjwal Rathore, Advait Subramanian, Julia Noack, Mathieu Hubert, Robert M. Stroud, Alan D. Frankel, Oren S. Rosenberg, Kliment A. Verba, David A. Agard, Mélanie Ott, Michael Emerman, Natalia Jura and 25 more - Nature 2020 cited by 4,888

  2. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 433

  3. NMDAR inhibition-independent antidepressant actions of ketamine metabolites

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2016 cited by 1,619

  4. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

    Authors: , , , , , , , - Nature Structural & Molecular Biology 2015 cited by 785

  5. Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 252

  6. Structure-based discovery of opioid analgesics with reduced side effects

    Authors: , , , , , , , , , , , , , , , , , , , - Nature, Nat. 2016 cited by 972

  7. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms

    Authors: , , , , , , , , , , , , , , , , , - Nature 2020 cited by 317

  8. Automated design of ligands to polypharmacological profiles

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 854

  9. Structures of the σ2 receptor enable docking for bioactive ligand discovery

    Authors: , , , , , , , , , , , , , , , - Nature 2021 cited by 194

  10. Structural insights into the human D1 and D2 dopamine receptor signaling complexes

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2021 cited by 264

  11. Structure, function and pharmacology of human itch GPCRs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 224

  12. Structure-based discovery of nonopioid analgesics acting through the α 2A -adrenergic receptor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 152

  13. Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled Receptors

    Authors: , , , , , , , , , , , , - Cell 2019 cited by 267

  14. Structure-based discovery of conformationally selective inhibitors of the serotonin transporter

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 2023 cited by 99

  15. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65

    Authors: , , , , , , , , , , , , , , , , , , - Nature, Nat. 2015 cited by 287

  16. Structure of the human κ-opioid receptor in complex with JDTic

    Authors: , , , , , , , , , , , , , , , - Nature 2012 cited by 878

  17. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C.H. Arrowsmith, Jian Jin - Nature Chemical Biology 2011 cited by 531

  18. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 377

  19. Molecular control of δ-opioid receptor signalling

    Authors: , , , , , , , - Nature 2014 cited by 503

  20. An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1

    Authors: , , , , , , , , , , , , , , , , , , , , , , - ACS Chemical Biology 2013 cited by 466

  21. A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuron 2015 cited by 398

  22. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor

    Authors: , , , , , , , , , , , , , , - Cell Research 2021 cited by 99

  23. Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator

    Authors: , , , , , , , , , , , , , , - Biochemistry 2023 cited by 71

  24. A Simple Representation of Three-Dimensional Molecular Structure

    Authors: , , , , , - Journal of Medicinal Chemistry 2017 cited by 146